The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $10.44

Today's change-0.24 -2.25%
Updated April 24 4:02 PM EDT. Delayed by at least 15 minutes.
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $10.44

Today's change-0.24 -2.25%
Updated April 24 4:02 PM EDT. Delayed by at least 15 minutes.

BioAmber Inc down (U.S.)$0.24

BioAmber Inc closed sharply lower Friday, dropping (U.S.)$0.24 or 2.25% to (U.S.)$10.44. Shares have lost 4.92% over the last five days, but have gained 24.43% over the last year to date. This security has underperformed the S&P 500 by 14.51% during the last year.

Key company metrics

  • Open(U.S.) $10.78
  • Previous close(U.S.) $10.68
  • High(U.S.) $10.96
  • Low(U.S.) $10.42
  • Bid / Ask-- / --
  • YTD % change+24.43%
  • Volume39,085
  • Average volume (10-day)51,945
  • Average volume (1-month)49,821
  • Average volume (3-month)43,775
  • 52-week range(U.S.) $7.38 to (U.S.) $15.29
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.41
Updated April 24 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-3,065.13%

BioAmber Inc has a net profit margin of -3,065.13%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:Basic MaterialsIndustry:Chemicals - Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit-2-1-20
Total cost of revenue2120
Total operating expense108118
Selling / general / administrative3354
Research & development4443
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)1000
Other operating expenses, total--------
Operating income-10-8-10-8
Interest income (expense), net non-operating00-10
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-8-14-20
Income after tax-5-8-14-20
Income tax, total0000
Net income-4-8-14-20
Total adjustments to net income--------
Net income before extra. items-4-8-14-20
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-8-14-20
Inc. avail. to common incl. extra. items-4-8-14-20
Diluted net income-4-8-14-20
Dilution adjustment0000
Diluted weighted average shares22211919
Diluted EPS excluding extraordinary itemsvalue per share-0.20-0.39-0.75-1.07
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.18-0.40-0.75-1.07